Publications by authors named "Peter Raubenheimer"

Claim this Profile
I
Implementation of a genotyped African population cohort, with virtual follow-up: A feasibility study in the Western Cape Province, South Africa.
Tsaone Tamuhla, Anna K Coussens, Maleeka Abrahams, Melissa J Blumenthal, Francisco Lakay, Peter Raubenheimer

Wellcome Open Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotype and predictors of insulin independence in adults presenting with diabetic ketoacidosis: a prospective cohort study.
Peter J Raubenheimer, Joanna Skelton, Bukiwe Peya, Joel A Dave, Naomi S Levitt

Diabetologia· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine health data describe adherence and persistence patterns for oral diabetes medication for a virtual cohort in the Khayelitsha sub-district of Cape Town, South Africa.
Tsaone Tamuhla, Peter Raubenheimer, Joel A Dave, Nicki Tiffin

PLOS Glob Public Health· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A description of the elevation of pericardial cortisol: cortisone ratio in patients with tuberculous pericarditis.
Justin Tapiwa Shenje, Peter Raubenheimer, Lubbe Wiesner, Ian Ross

Front Endocrinol (Lausanne)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2A Trial of the Safety and Tolerability of Increased Dose Rifampicin and Adjunctive Linezolid, With or Without Aspirin, for Human Immunodeficiency Virus-Associated Tuberculous Meningitis: The LASER-TBM Trial.
Angharad G Davis, Sean Wasserman, Cari Stek, Mpumi Maxebengula, C Jason Liang, Peter Raubenheimer

Clin Infect Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.
Mary-Ann Davies, Erna Morden, Petro Rousseau, Juanita Arendse, Jamy-Lee Bam, Peter Raubenheimer

Int J Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to a care bundle for bacteraemia: A retrospective cohort study.
Elizabeth M Gatley, Tom Boyles, Sipho Dlamini, Marc Mendelson, Phiona E Namale, Peter J Raubenheimer

S Afr J Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial.
Kelley R H Branch, Gilles R Dagenais, Alvaro Avezum, Jan Basile, Ignacio Conget, Peter J Raubenheimer

Eur J Heart Fail· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.
Hertzel C Gerstein, Chinthanie Ramasundarahettige, Alvero Avezum, Jan Basile, Ignacio Conget, Peter J Raubenheimer

Cardiovasc Diabetol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study.
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, Carolyn Williamson, Ziyaad Valley-Omar, Peter Raubenheimer

Gates Open Res· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial.
Tali Cukierman-Yaffe, Hertzel C Gerstein, Jan Basile, M Angelyn Bethel, Ernesto G Cardona-Muñoz, Peter J Raubenheimer

J Clin Endocrinol Metab· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa.
Mary-Ann Davies, Erna Morden, Petro Rosseau, Juanita Arendse, Jamy-Lee Bam, Peter Raubenheimer

medRxiv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.
Mary-Ann Davies, Reshma Kassanjee, Petro Rousseau, Erna Morden, Leigh Johnson, Peter Raubenheimer

Trop Med Int Health· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the clinical severity of the Omicron variant in the Western Cape Province, South Africa, using the diagnostic PCR proxy marker of RdRp target delay to distinguish between Omicron and Delta infections - a survival analysis.
Hannah Hussey, Mary-Ann Davies, Alexa Heekes, Carolyn Williamson, Ziyaad Valley-Omar, Peter Raubenheimer

Int J Infect Dis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Delphi study to guide the development of a clinical indicator tool for palliative care in South Africa.
Rene Krause, Alan Barnard, Henriette Burger, Andre De Vos, Katya Evans, Peter Raubenheimer

Afr J Prim Health Care Fam Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
Peter J Raubenheimer, William C Cushman, Alvaro Avezum, Jan Basile, Ignacio Conget

Diabetes Obes Metab· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of laboratory-confirmed SARS-CoV-2 infection in the Omicron-driven fourth wave compared with previous waves in the Western Cape Province, South Africa.
Mary-Ann Davies, Reshma Kassanjee, Petro Rosseau, Erna Morden, Leigh Johnson, Peter Raubenheimer

medRxiv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year mortality after hospital admission as an indicator of palliative care need: A retrospective cohort study.
P Frankenfeld, L Van Niekerk, K Manning, N Tiffin, Peter Raubenheimer

S Afr Med J· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes in a TB and HIV-endemic South African population: Analysis of a virtual cohort using routine health data.
Tsaone Tamuhla, Joel A Dave, Peter Raubenheimer, Nicki Tiffin

PLoS One· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial.
Harpreet S Bajaj, Hertzel C Gerstein, Purnima Rao-Melacini, Jan Basile, Helen Colhoun, Peter Raubenheimer

Lancet Diabetes Endocrinol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Giulia Ferrannini, Hertzel Gerstein, Helen Martina Colhoun, Gilles R Dagenais, Rafael Diaz, Peter Johann Raubenheimer

Eur Heart J· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for COVID-19 hospitalisation and death in people living with diabetes: A virtual cohort study from the Western Cape Province, South Africa.
Joel A Dave, Tsaone Tamuhla, Nicki Tiffin, Naomi S Levitt, Ian L Ross, Peter J Raubenheimer

Diabetes Res Clin Pract· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol for a phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis [LASER-TBM].
Angharad G Davis, Sean Wasserman, Mpumi Maxebengula, Cari Stek, Marise Bremer, Peter Raubenheimer

Wellcome Open Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial.
Matthew C Riddle, Hertzel C Gerstein, Denis Xavier, William C Cushman, Lawrence A Leiter, Peter J Raubenheimer

J Clin Endocrinol Metab· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis.
Gilles R Dagenais, Lars Rydén, Lawrence A Leiter, Mark Lakshmanan, Leanne Dyal, Peter J Raubenheimer

Cardiovasc Diabetol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis